Medgold Resources is pleased to report excellent first-pass sampling results from recent work at its wholly-owned Vila de Rei gold project in central Portugal. The project covers 40 line km of a regional structure which is known to contain multiple gold-bearing zones. Preliminary exploration at the Pampilhal prospect has outlined highly anomalous gold mineralisation associated with silicification over a 2.4 km by 1.3 km [...]
Medgold Resources is pleased to announce results of recently completed exploration at its wholly-owned Pietratonda licence in the Colline Metallifere of Central Italy. Dan James, President of Medgold, said, "The current work has outlined a large gold-antimony anomaly and highlights the exciting potential of the Colline Metallifere of Central Italy. We believe that the gold mineralization is controlled by high-angle [...]
Medgold is pleased to advise that it has closed its previously announced $975,000 convertible debenture private placement. The debentures are convertible into 6,500,000 common shares of the Company for two years from closing at the rate of $0.15 per share. The debenture holder has also been issued warrants to purchase up to 6,500,000 additional common shares at $0.15 per share, exercisable for one year from the date of [...]
Medgold is pleased to announce that it has now completed the application process and paid all relevant taxes for three contiguous gold exploration permits covering 79 square kilometres in southern Galicia. Dan James, President of Medgold, said, "This transaction marks our entry into Spain. We believe the entire region is highly prospective, already hosting several advanced gold projects. We have identified a 14 km linear [...]
Medgold Resources is pleased to announce that it has been issued the highly prospective 300 square kilometer Vila de Rei gold exploration licence in central Portugal. Licence located in highly prospective central Portuguese region. High-grade rock grab samples, from trace up to 24.7 g/t Au. Over 40 km of structure identified already. Exploration work to commence immediately over key prospect
Medgold is pleased to announce that it has arranged, subject to Exchange approval, a $975,000 non-brokered private placement financing of debentures which are convertible into 6,500,000 common shares of the Company at the rate of $0.15 per share. The debentures will bear interest at the rate of 8% per annum and are convertible into shares for a period of up to two years from closing of the financing. The debenture holders [...]
+500,00 %
-70,00 %
